These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24175086)

  • 1. Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.
    Meusburger E; Mündlein A; Zitt E; Obermayer-Pietsch B; Kotzot D; Lhotta K
    Clin Kidney J; 2013 Apr; 6(2):211-215. PubMed ID: 24175086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia.
    Nizar R; Cantley NWP; Tang JCY
    Endocrinol Diabetes Metab Case Rep; 2021 Sep; 2021():. PubMed ID: 34551392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations.
    Janiec A; Halat-Wolska P; Obrycki Ł; Ciara E; Wójcik M; Płudowski P; Wierzbicka A; Kowalska E; Książyk JB; Kułaga Z; Pronicka E; Litwin M
    Nephrol Dial Transplant; 2021 Jul; 36(8):1484-1492. PubMed ID: 33099630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure.
    Colussi G; Ganon L; Penco S; De Ferrari ME; Ravera F; Querques M; Primignani P; Holtzman EJ; Dinour D
    Nephrol Dial Transplant; 2014 Mar; 29(3):636-43. PubMed ID: 24235083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).
    De Paolis E; Minucci A; De Bonis M; Scaglione GL; Gervasoni J; Primiano A; Ferraro PM; Cappellani D; Marcocci C; Gambaro G; Capoluongo E
    Clin Chim Acta; 2018 Jul; 482():8-13. PubMed ID: 29574006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
    Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
    J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole.
    Sayers J; Hynes AM; Srivastava S; Dowen F; Quinton R; Datta HK; Sayer JA
    Clin Kidney J; 2015 Aug; 8(4):453-5. PubMed ID: 26251716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
    Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
    Arnold N; O'Toole V; Huynh T; Smith HC; Luxford C; Clifton-Bligh R; Eastman CJ
    Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31751313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia.
    Gigante M; Santangelo L; Diella S; Caridi G; Argentiero L; D''Alessandro MM; Martino M; Stea ED; Ardissino G; Carbone V; Pepe S; Scrutinio D; Maringhini S; Ghiggeri GM; Grandaliano G; Giordano M; Gesualdo L
    Nephron; 2016; 133(3):193-204. PubMed ID: 27394135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
    Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
    Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia.
    Madsen JOB; Sauer S; Beck B; Johannesen J
    J Clin Res Pediatr Endocrinol; 2018 Mar; 10(1):83-86. PubMed ID: 28874334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
    Güven A; Konrad M; Schlingmann KP
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.
    Tray KA; Laut J; Saidi A
    Conn Med; 2015; 79(10):593-7. PubMed ID: 26731879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in CYP24A1 and idiopathic infantile hypercalcemia.
    Schlingmann KP; Kaufmann M; Weber S; Irwin A; Goos C; John U; Misselwitz J; Klaus G; Kuwertz-Bröking E; Fehrenbach H; Wingen AM; Güran T; Hoenderop JG; Bindels RJ; Prosser DE; Jones G; Konrad M
    N Engl J Med; 2011 Aug; 365(5):410-21. PubMed ID: 21675912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.
    Jobst-Schwan T; Pannes A; Schlingmann KP; Eckardt KU; Beck BB; Wiesener MS
    Kidney Blood Press Res; 2015; 40(5):443-51. PubMed ID: 26304832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes.
    Griffin TP; Joyce CM; Alkanderi S; Blake LM; O'Keeffe DT; Bogdanet D; Islam MN; Dennedy MC; Gillan JE; Morrison JJ; O'Brien T; Sayer JA; Bell M; O'Shea PM
    Endocr Connect; 2020 Jun; 9(6):530-541. PubMed ID: 32375123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.
    Schlingmann KP; Ruminska J; Kaufmann M; Dursun I; Patti M; Kranz B; Pronicka E; Ciara E; Akcay T; Bulus D; Cornelissen EA; Gawlik A; Sikora P; Patzer L; Galiano M; Boyadzhiev V; Dumic M; Vivante A; Kleta R; Dekel B; Levtchenko E; Bindels RJ; Rust S; Forster IC; Hernando N; Jones G; Wagner CA; Konrad M
    J Am Soc Nephrol; 2016 Feb; 27(2):604-14. PubMed ID: 26047794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.